Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This effect is dose-dependent, peaks around week 24, and diminishes thereafter even with continued treatment
Tirzepatide is a dual-action agonist as it enhances both GLP-1 and another hormone known as glucose-dependent insulinotropic polypeptide (GIP) to improve blood sugar control as well as reduce appetite and food intake
Many patients experience reduced appetite and fluid intake when starting GLP-1 therapy, whilst the medicine's gastrointestinal effects including nausea and occasional vomiting can further affect hydration status
Months one through three: the silent phase During the first one to three months of GLP-1 therapy, you are unlikely to notice any change in your hair
Already theres evidence GLP-1 users are buying different products at the grocery store
US$ 21.37
US$ 22.23
US$ 24.29
US$ 26.75
US$ 21.78
US$ 21.37
